Novel targeted drugs approved by the NMPA and FDA in 2019
Open Access
- 8 May 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 5 (1), 1-4
- https://doi.org/10.1038/s41392-020-0164-4
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- 2019 FDA drug approvalsNature Reviews Drug Discovery, 2020
- Antibody–drug conjugates for cancerThe Lancet, 2019
- 2018 FDA drug approvalsNature Reviews Drug Discovery, 2019